MIRA INFORM REPORT

 

 

Report Date :

15.11.2014

 

IDENTIFICATION DETAILS

 

Name :

CHEMIDRUG INDUSTRIES PVT. LTD.

 

 

Registered Office :

Amil Bhawan Ghantaghar Kathmandu, Post Box: 186

 

 

Country :

Nepal

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

05.03.2001

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacturer and Trader of Drugs.

 

 

No. of Employees :

360

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Nepal

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

NEPAL - ECONOMIC OVERVIEW

 

Nepal is among the poorest and least developed countries in the world, with about one-quarter of its population living below the poverty line. Nepal is heavily dependent on remittances, which amount to as much as 22-25% of GDP. Agriculture is the mainstay of the economy, providing a livelihood for more than 70% of the population and accounting for a little over one-third of GDP. Industrial activity mainly involves the processing of agricultural products, including pulses, jute, sugarcane, tobacco, and grain. Nepal has considerable scope for exploiting its potential in hydropower, with an estimated 42,000 MW of commercially feasible capacity, but political uncertainty and a difficult business climate have hampered foreign investment. Additional challenges to Nepal's growth include its landlocked geographic location, persistent power shortages, underdeveloped transportation infrastructure, civil strife and labor unrest, and its susceptibility to natural disaster. The lack of political consensus in the past several years has delayed national budgets and prevented much-needed economic reform, although the government passed a full budget in 2013.

 

 

Source : CIA

 

 

 

Company Identification Details

 

Enquired Name

:

Chemidrug industries Pvt. Ltd.

Correct Name of Company

:

Chemidrug industries Pvt. Ltd.

Registered Office

:

Amil Bhawan
Ghantaghar
Kathmandu, Nepal
Post Box: 186

Phone: 977-1-4272948/4221841/51
Fax: 977-1-4277996/4242451
Email: chemi_drug@yahoo.com

Factory

:

Thamkot Khanmandal Nepal 186

Industry

:

Drugs

Nature of Activity

:

Manufacturer and Trader of Drugs.

 

 

Precious product for........... Precious people......

CDPL PRODUCT NOMENCLATURE

S.N

Product Name

Generic Name

Strength

Pack Size

ANALGESICS/ ANTIPYRETICS

Polar Tab

Paracetamol

500mg

20*10

Polar Susp

Paracetamol

125mg/5ml

60ml

Chembufen Tab

Paracetamol+lbuprofen

325mg+400mg

20*10

ANTHELMINTICS

Opel Tab

Albendazole

400mg

1*50

Opel Susp

Albendazole

200mg/5ml

10ml

Piperazine Syp

Piperazine Citrate

750mg/5ml

30ml

ANTIBACTERIALS

Roxil 150 Tab

Roxithromycin

150mg

10*10

Roxil 50 DT

Roxithromycin

50mg

10*10

Prof 500 Tab

Ciprofloxacin HCL

500mg

10*10

Chemtrim Susp

Sulfamethoxazole + Trimethoprim

400mg+80mg/5ml

60ml

Chemtrim Ds Tab

Sulfamethoxazole + Trimethoprim

800mg+160mg

10*10

ANTIBIOTICS

Amoclox Caps

Amoxycillin+Cloxacillin

250mg+250mg

20*10

Amoclox Kid Tab

Amoxycillin+Cloxacillin

125mg+125mg

10*10

Amoclox Dry Syp

Amoxycillin+Cloxacillin

125mg+125mg/5ml

60ml

Sumox 500 Cap

Amoxycillin

500mg

20*10

Sumox 250 Cap

Amoxycillin

250mg

10*10

Sumox 250DT

Amoxycillin

250mg

15*10

Sumox 125 DT

Amoxycillin

125mg

15*10

Sumox Dry Syp

Amoxycillin

125mg/5ml

60ml

Sumox Drops

Amoxycillin

100mg/ml

10ml

Chemclox 500

Cloxacillin

500mg

20*10

Clo-Ampi Cap

Ampicillin+cloxacillin

250mg+250mg

20*10

Chemocycline500 caps

Tetracycline

500mg

20*10

Doxil 500 Caps

Cefadroxil

500mg

10*10

Doxil 250 DT

Cefadroxil

250mg

10*10

Doxil Dry Syp

Cefadeoxil

125mg/5ml

60ml

Doxan Caps

Doxycycline

100mg

20*10

Lix 500 Caps

Cefalexin

500mg

10*10

Lix 125 DT

Cefalexin

125mg

10*10

Lix Dry Syp

Cefalexin

125mg/5ml

60ml

ANTI FUNGAL

Flucap Caps

Fluconazole

150mg

1*30

ANTIRHEUMATICS

C-Nim Tab

Nimesulide

50mg

25*10

C-Nac Tab

Diclofenac sodium

50mg

20*10

ANTI-ULCERANTS / ANTACIDS

Pantex- 40 Tab

Pantoprazole Sodium

40mg

10*10

Pantex- 20 Tab

Pantoprazole Sodium

20mg

10*10

Omil- 20 Tab

Omeprazole

20mg

10*10

Hiloc- 150 Tab

Ranitidine HCL

20mg

10*10

Gastric Gel Susp

Aluminium Hydroxide+ Magnesium Hydroxide

125mg+250mg/5ml

170ml

ANTI-DIARRHOEAL

Ogyl-Df Tab

Metronidazole+Diloxanide Furoate

400mg+500mg

20*10

Ogyl-Df Susp

Metronidazole+Diloxanide Furoate

200mg+250mg/5ml

60ml

Ogyl- 400 Tab

Metronidazole

400mg

20*10

ANTI-alLERGICS/ ANTIHISTAMINICS

Zin-10 Tab

Cetirizine HCL

10mg

3*10*10

Zin Syp

Cetirizine HCL

5mg/5ml

60ml

Co- Ex Syp

Phenylpropanolamine HCL+ Chlorpheniramine Maleate

2mg+12.5mg/5ml

100ml

COUGH PREPARATIONS

Rinixin Dx Syp

Dextromethorphan HBr+

Phenyl Propanolamine

HCL +Pheniramine Maleate

6.75mg+7.5mg+7.5/5ml

100ml/50ml

Chemis Expectorant

Bromhexine HCL+ Ammonium Chloride+ Pheniramine Maleate

4mg+100mg+2mg/5ml

100ml

Coscoryl Expectorant

Salbutamol Sulphate+ Bromhexine

2mg+4mg/5ml

100ml

ANTI-COLD

Coldchem Tab

Paracetamol+ Phenylpropanolamine HCL+ Chlorpheniramine Maleate

500mg + 25mg + 4mg

25*10

Coldchem Syp

Paracetamol + Phenylpropanolamine HCL + Chlorpheniramine Maleate

125mg + 12.5mg+1.0mg/5ml

60ml

DIGESTIVE ENZYMES

Heptazyme Syp

Deastase+ Pepsin

50mg + 10mg /5ml

200ml /100 ml

APETIZERS / ANTIHISTAMINICS

Cypotone Syp

Cyproheptadine HCL

2mg/ 5ml

200ml/100ml

VITAMINS / HAEMATINICS

Vitabic- Forte Caps

Vitamin B- Complex

Multi Ingredients

20*10

Virabic – Forte Syp

Vitamin B complex + Folic Acid

Multi Ingredients

200ml*100ml

Multivees Caps

Vitamin B- complex + Iron

Multi Ingredients

20*10

BC- Tabs

Vitamin B- complex

Multi Ingredients

3*10*10

ANTI- EMETICS

Opram Tab

Metoclorpramide HCL

10mg

3*10*10

DERMATOlOGICAlS

Borozinc Creams

Boric acid + Zincoxide +Tincture Calendula +Gambier

1%+ 1% + 4.5% +0.5%

10mg

 

Official Company Data

 

Legal Form

:

Private Limited Company
Corporate Identity Number (CIN)

:

15864
ROC Code 

:

Kathmandu, Nepal

Registration Date

:

05.03.2001
Employee

:
360

Auditor

:

 

S. Sreshtha & Co., Nepal

 
Bankers

:

Nepal Tourism Development Bank

Nepal Grindlays Bank, Ltd.

Nevil Bank Limited
Customer

:

United drugs center , Nepalganj

Pooja medicine Suppliers, Katmandu

Supplier

:

Sudarshan Trading Company Limited

Plus Creation Private Limited

 

 

Financial

 
Authorised Capital

:

10,000,000/-
Paid-up Capital

:
1,000,000/-

 

 

BALANCE SHEET        

 

Balance Sheet

 (Amount in Rupees Mln.)

 

BALANCE SHEET AS AT 31.03.2012

Liabilities

Amount (Rs.)

 

Assets

Amount (Rs.)

 

 

 

 

 

Paid up Capital

1,000,000

 

Fixed Assets

10,947

Reserve & Surplus

10,618,987

 

Investments

3,000,000

Deffered Tax

8,944

 

Loans & Advances

15,348,954

Current Liabilities & Prov.

13,481,829

 

Cash & Bank

6,749,859

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

25,109,760

 

 

25,109,760

 

 

 

 

 

 

Rs.

 

Sales

21,036,920

 

Profit before Tax

10,382,600

 

Profit after Tax

6,568,911

 

 

 

 

 

 

 

Particulars

 

 

31.03.2014

31.03.2013

Sales Turnover (Approximately)

 

220.000

150.000

 

 

 

 

 

Expected Sales ( 2014-2015 ) : Rs.300.000 Millions

 

The above information has been parted by Mr. Balkrishna K. C. (Accounts Head)

 

 

Board of Directors

 

Prabhat Prakash Saakha

Uttam Deea

Rajesh Karma Charya

Sarada Amatya

Kabir Prasad Dwa

Gagan Shrestha (9851122119)

Gopal Khatiwada (9851122556)

Rajesh Shrestha

 

 

INFORMATION PARTED BY

 

Name :

Mr. Balkrishna K. C.

Designation :

Accounts Head

Contact No.:

927-1-4221841

Date :

10.11.2014

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.61.65

UK Pound

1

Rs.96.54

Euro

1

Rs.76.70

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

SNT

 

               


 

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.